BECKHAM
21-07-2015, 03:20 PM
Swiss pharmaceutical giant Novartis reported $4.1 billion (€3.8 billion) in income for the first half of the year, down 20 percent, due largely to a stronger dollar.
for more... (http://www.thelocal.ch/20150721/strong-dollar-takes-bite-out-of-novartis-sales-switzerland-pharm)
for more... (http://www.thelocal.ch/20150721/strong-dollar-takes-bite-out-of-novartis-sales-switzerland-pharm)